Advances in treatment decision-making for extrahepatic recurrence of intrahepatic cholangiocarcinoma
Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 12
Abstract
There has been a constant increase in the incidence rate of intrahepatic cholangiocarcinoma in China， and as a highly fatal malignancy， it often has an extremely poor prognosis. Surgical resection is the only possible way to cure this disease， but postoperative recurrence rate reaches as high as 50% — 70%. While recurrence is commonly observed in the liver， 15% — 30% of patients may experience extrahepatic recurrence. There are relatively few studies in the treatment strategies for extrahepatic recurrence， and there are still no clear guidelines for recommendation. Chemotherapy is currently the main treatment method for this disease. Studies have shown that some patients man achieve a prolonged survival time through surgical resection of extrahepatic recurrence sites， and in particular， such surgery is more feasible in patients with single focal lesion during recurrence. Nevertheless， surgery is only suitable to a small number of patients， and most patients still need to rely on systemic therapy and local treatment. Through a comprehensive analysis of related articles， this article summarizes the key influencing factors for extrahepatic recurrence， discusses the indications for surgery， and emphasizes the importance of individualized treatment strategies， in order to provide a reference for future treatment modalities.
Authors and Affiliations
Yihang WANG, Jiangtao LI
Keywords
Related Articles
- EP ID EP753958
- DOI 10.12449/JCH241204
- Views 27
- Downloads 0
Expression and prognostic value of triggering receptor expressed on myeloid cells-1 in patients with cirrhotic ascites and intra-abdominal infection
[Objective] To analyze the expression level of triggering receptor expressed on myeloid cells-1 （TREM-1） in serum and ascites of patients with cirrhotic ascites， and to investigate its correlation with clinical featur...
Advances， achievements， and challenges in action to eliminate hepatitis C as a public health threat in China
In 2016， the World Health Organization proposed the vision of eliminating viral hepatitis as a public health threat by 2030， and since then， China has actively promoted the elimination of hepatitis C as a public healt...
Features of intestinal flora in patients with nonalcoholic fatty liver disease and Helicobacter pylori infection
[Objective] To investigate the features and mechanism of action of intestinal flora in patients with nonalcoholic fatty liver disease （NAFLD） and Helicobacter pylori （HP） infection by comparing the changes in intesti...
Rheumatic diseases and portal hypertension
Rheumatic diseases are a group of chronic disorders characterized by abnormalities in the immune system， while portal hypertension occurs due to increased blood flow or heightened resistance in the portal venous system...
Changes in hemoglobin and related influencing factors in patients with liver failure undergoing artificial liver support therapy
[Objective] To investigate the changing trend of hemoglobin （Hb） and related influencing factors in patients with liver failure after artificial liver support system （ALSS） therapy. [Methods] A total of 106 patients...